Shopping Cart
- Remove All
- Your shopping cart is currently empty
ZYDPLA1 is an innovative, next-generation oral DPP-4 inhibitor developed for the treatment of type 2 diabetes.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | ZYDPLA1 is an innovative, next-generation oral DPP-4 inhibitor developed for the treatment of type 2 diabetes. |
Alias | ZYDPLA-1, ZYDPLA 1 |
Molecular Weight | 491.52 |
Formula | C24H21N5O5S |
Cas No. | 1263402-76-1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.